Medical Affairs Agentic Enablement
Agentic systems shaped to Medical Affairs reality
MSL effectiveness models, medical content workflows, field medical use-case design, PV-adjacent automation, and governance models that survive privacy and pharmacovigilance review. Built for pharma, biotech, and medical-device Medical Affairs functions.
How this work runs
Medical Affairs is often where AI becomes concrete first. But it lives inside a design surface shaped by PV, off-label risk, content review, privacy, and the medical-commercial firewall. Treating those as review steps instead of design conditions is the fastest way to produce a pilot that goes nowhere.
When this fits
- A Medical Affairs leader has a stalled pilot or a board-asked AI mandate
- MSL effectiveness or content operations need an operating-model upgrade, not just a tool
- PV-adjacent automation needs to be designed safely from the start, not bolted on at review
- Pre-launch window with Medical leading market shaping
What you get
- MSL effectiveness models grounded in real field workflow
- Medical content workflows that handle review timing, escalation logic, and ownership clarity
- Governance models built to pass medical review the first time, not the third
- AI monitoring and recommendation engine that ensures your very latest advances in medicine and science are appearing in the right gen AI platforms (e.g. Open Evidence, ChatGPT, Claude, university research LLMs, etc.)
- KOL identification based on agentically derived profile and true amplification potential, not just speaker appearances.